CSPC Pharmaceutical Group Limited (CSPCY)

USD 3.05

(-2.71%)

Total Assets Summary of CSPC Pharmaceutical Group Limited

CSPC Pharmaceutical Group Limited's latest annual total assets in 2023 was 46.28 Billion CNY , up 10.8% from previous year.
CSPC Pharmaceutical Group Limited's latest quarterly total assets in 2023 FY was 46.28 Billion CNY , up 10.8% from previous quarter.
CSPC Pharmaceutical Group Limited reported annual total assets of 41.76 Billion CNY in 2022, up 20.23% from previous year.
CSPC Pharmaceutical Group Limited reported annual total assets of 34.74 Billion CNY in 2021, up 15.53% from previous year.
CSPC Pharmaceutical Group Limited reported quarterly total assets of - CNY for 2023 Q1, down -100.0% from previous quarter.
CSPC Pharmaceutical Group Limited reported quarterly total assets of 43.67 Billion CNY for 2023 Q2, down 0.0% from previous quarter.

Annual Total Assets Chart of CSPC Pharmaceutical Group Limited (2023 - 2003)

Historical Annual Total Assets of CSPC Pharmaceutical Group Limited (2023 - 2003)

Year	Total Assets	Total Assets Growth
2023	46.28 Billion CNY	10.8%
2022	41.76 Billion CNY	20.23%
2021	34.74 Billion CNY	15.53%
2020	30.07 Billion CNY	14.26%
2019	26.31 Billion CNY	15.97%
2018	22.69 Billion HKD	26.07%
2017	18 Billion HKD	36.2%
2016	13.21 Billion HKD	17.21%
2015	11.27 Billion HKD	13.45%
2014	9.93 Billion HKD	5.5%
2013	9.42 Billion HKD	-13.47%
2012	10.88 Billion HKD	22.76%
2011	8.86 Billion HKD	7.08%
2010	8.28 Billion HKD	5.02%
2009	7.88 Billion HKD	13.33%
2008	6.95 Billion HKD	238.02%
2007	2.05 Billion HKD	-61.0%
2006	5.27 Billion HKD	-5.55%
2005	5.58 Billion HKD	11.44%
2004	5.01 Billion HKD	40.26%
2003	3.57 Billion HKD	0.0%

Year	Total Assets	Total Assets Growth
2023 FY	46.28 Billion CNY	10.8%
2023 Q1	- CNY	-100.0%
2023 Q2	43.67 Billion CNY	0.0%
2023 Q3	- CNY	-100.0%
2023 Q4	46.28 Billion CNY	0.0%
2022 Q2	38.83 Billion CNY	0.0%
2022 Q4	41.76 Billion CNY	0.0%
2022 FY	41.76 Billion CNY	20.23%
2021 Q4	34.74 Billion CNY	0.0%
2021 FY	34.74 Billion CNY	15.53%
2021 Q2	32.85 Billion CNY	0.0%
2020 FY	30.07 Billion CNY	14.26%
2020 Q2	29.16 Billion CNY	0.0%
2020 Q4	30.07 Billion CNY	0.0%
2019 Q2	24.32 Billion CNY	0.0%
2019 FY	26.31 Billion CNY	15.97%
2019 Q4	26.31 Billion CNY	0.0%
2018 Q2	21.84 Billion HKD	0.0%
2018 FY	22.69 Billion HKD	26.07%
2018 Q4	22.69 Billion HKD	0.0%
2017 Q4	18 Billion HKD	0.0%
2017 Q2	14.51 Billion HKD	0.0%
2017 FY	18 Billion HKD	36.2%
2016 FY	13.21 Billion HKD	17.21%
2016 Q2	12.03 Billion HKD	0.0%
2016 Q4	13.21 Billion HKD	0.0%
2015 Q4	11.27 Billion HKD	0.0%
2015 Q2	10.96 Billion HKD	0.0%
2015 FY	11.27 Billion HKD	13.45%
2014 FY	9.93 Billion HKD	5.5%
2014 Q4	9.93 Billion HKD	0.0%
2014 Q2	9.75 Billion HKD	0.0%
2013 Q2	10.11 Billion HKD	0.0%
2013 Q4	9.42 Billion HKD	0.0%
2013 FY	9.42 Billion HKD	-13.47%
2012 FY	10.88 Billion HKD	22.76%
2012 Q4	10.88 Billion HKD	0.0%
2012 Q2	8.35 Billion HKD	0.0%
2011 FY	8.86 Billion HKD	7.08%
2011 Q2	8.55 Billion HKD	0.0%
2011 Q4	8.86 Billion HKD	0.0%
2010 Q4	8.28 Billion HKD	0.0%
2010 FY	8.28 Billion HKD	5.02%
2010 Q2	7.99 Billion HKD	0.0%
2009 Q4	7.88 Billion HKD	0.0%
2009 FY	7.88 Billion HKD	13.33%
2008 FY	6.95 Billion HKD	238.02%
2007 FY	2.05 Billion HKD	-61.0%
2006 FY	5.27 Billion HKD	-5.55%
2005 FY	5.58 Billion HKD	11.44%
2004 FY	5.01 Billion HKD	40.26%
2003 FY	3.57 Billion HKD	0.0%

Peer Total Assets Comparison of CSPC Pharmaceutical Group Limited

Name	Total Assets	Total Assets Difference
AstraZeneca PLC	100.97 Billion USD	54.165%
Bristol-Myers Squibb Company PFD CONV 2	95.15 Billion USD	51.363%
CSPC Pharmaceutical Group Limited	6.52 Billion USD	-609.412%
Clarus Therapeutics Holdings, Inc.	51.7 Million USD	-89406.788%
Novartis AG	99.94 Billion USD	53.692%
PT Kalbe Farma Tbk.	1.75 Billion USD	-2531.55%